Sales decline 19.55% to Rs 62.44 crore
Net Loss of Parenteral Drugs (India) reported to Rs 31.77 crore in the quarter ended June 2017 as against net loss of Rs 25.23 crore during the previous quarter ended June 2016. Sales declined 19.55% to Rs 62.44 crore in the quarter ended June 2017 as against Rs 77.61 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales62.4477.61 -20 OPM %-13.85-3.20 -PBDT-31.02-23.14 -34 PBT-37.04-29.09 -27 NP-31.77-25.23 -26Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)